Table 2. Metabolic characteristics of the study population.

	Control group N= 763	pCAD group N= 948	P
Total-Cholesterol (mg/dL)	192.09 ± 35.8	165.83 ± 46.92	< 0.001
HDL-C (mg/dL)	50.06 ± 14.39	41.28 ± 10.85	< 0.001
LDL-C (mg/dL)	116.46 ± 31.22	96.31 ± 38.92	< 0.001
TG (mg/dL)	160.78 ± 100.34	175.83 ± 101.32	0.007
Glucose (mg/dL)	96.08 ± 31.20	103.06 ± 34.74	< 0.001
Insulin (mg/dL)	18.89 ± 9.63	23.06 ± 14.97	< 0.001
HOMA-IR	4.54 ± 2.95	5.82 ± 4.68	< 0.001
Uric acid (mg/dL)	5.10 ± 1.31	6.40 ± 1.61	< 0.001
Creatinine (mg/dL)	0.78 ± 0.17	1.00 ± 0.17	< 0.001
ALT (IU/L)	27.36 ± 19.55	29.8 ± 19.97	0.023
AST (IU/L)	27.35 ± 12.62	28.07 ± 10.59	0.606
ALP (IU/L)	84.59 ± 25.95	80.49 ± 25.49	0.005
ApoB (mg/dL)	92.01 ± 27.00	83.10 ± 31.05	< 0.001
ApoA (mg/dL)	143.03 ± 34.39	127.34 ± 27.00	< 0.001
T2DM (%)	9.7	23.1	< 0.001

Data are expressed as means ± SD. HDL-C: High density lipoprotein-Cholesterol, LDL-C: Low density lipoprotein-Cholesterol, TG: Triglycerides, HOMA: Homeostatic model in insulin resistance, ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, ALP: Alkaline phosphatase, T2DM: Type 2 Diabetes mellitus